Consultants in Medical Oncology/Hematology

Drexel Hill, Pennsylvania 19026

0 studies enrolling now · 6 studies all time

What they study most

Colonic Neoplasms, Colorectal Neoplasms, Diarrhea, Metastatic Breast Cancer, Neoplasms, Prostate Cancer, Rectal Neoplasms, Small Cell Lung Cancer

Studies at this site

• A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer — Completed
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer — Completed
• STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea — Completed
• Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer — Completed
• DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) — Stopped early